The medicine with elamipretide as the principle raw material have entered the third section of clinical follow.Elamipretide triacetate can be an aromatic-cationic tetrapeptide that targets the mitochondrial intima and is also an inhibitor of cardiolipin peroxidase. It very easily penetrates mobile membranes and is Utilized in therapeutic trials inv